Antonella Converso - Publications

2003 Scripps Research Institute, La Jolla, La Jolla, CA, United States 

11 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2016 Finley M, Cassaday J, Kreamer T, Li X, Solly K, O'Donnell G, Clements M, Converso A, Cook S, Daley C, Kraus R, Lai MT, Layton M, Lemaire W, Staas D, et al. Kinetic Analysis of Membrane Potential Dye Response to NaV1.7 Channel Activation Identifies Antagonists with Pharmacological Selectivity against NaV1.5. Journal of Biomolecular Screening. PMID 26861708 DOI: 10.1177/1087057116629669  0.96
2014 Converso A, Hartingh T, Fraley ME, Garbaccio RM, Hartman GD, Huang SY, Majercak JM, McCampbell A, Na SJ, Ray WJ, Savage MJ, Wolffe C, Yeh S, Yu Y, White R, et al. Adenosine analogue inhibitors of S-adenosylhomocysteine hydrolase. Bioorganic & Medicinal Chemistry Letters. 24: 2737-40. PMID 24813734 DOI: 10.1016/J.Bmcl.2014.04.034  0.96
2011 Vardigan JD, Converso A, Hutson PH, Uslaner JM. The selective phosphodiesterase 9 (PDE9) inhibitor PF-04447943 attenuates a scopolamine-induced deficit in a novel rodent attention task. Journal of Neurogenetics. 25: 120-6. PMID 22070409 DOI: 10.3109/01677063.2011.630494  0.96
2011 Hutson PH, Finger EN, Magliaro BC, Smith SM, Converso A, Sanderson PE, Mullins D, Hyde LA, Eschle BK, Turnbull Z, Sloan H, Guzzi M, Zhang X, Wang A, Rindgen D, et al. The selective phosphodiesterase 9 (PDE9) inhibitor PF-04447943 (6-[(3S,4S)-4-methyl-1-(pyrimidin-2-ylmethyl)pyrrolidin-3-yl]-1-(tetrahydro-2H-pyran-4-yl)-1,5-dihydro-4H-pyrazolo[3,4-d]pyrimidin-4-one) enhances synaptic plasticity and cognitive function in rodents. Neuropharmacology. 61: 665-76. PMID 21619887 DOI: 10.1016/J.Neuropharm.2011.05.009  0.96
2009 Converso A, Hartingh T, Garbaccio RM, Tasber E, Rickert K, Fraley ME, Yan Y, Kreatsoulas C, Stirdivant S, Drakas B, Walsh ES, Hamilton K, Buser CA, Mao X, Abrams MT, et al. Development of thioquinazolinones, allosteric Chk1 kinase inhibitors. Bioorganic & Medicinal Chemistry Letters. 19: 1240-4. PMID 19155174 DOI: 10.1016/J.Bmcl.2008.12.076  0.96
2006 Díaz DD, Converso A, Sharpless KB, Finn MG. 2,6-Dichloro-9-thiabicyclo[3.3.1]nonane: multigram display of azide and cyanide components on a versatile scaffold. Molecules (Basel, Switzerland). 11: 212-8. PMID 17962753 DOI: 10.3390/11040212  0.96
2005 Nicolaou KC, Sasmal PK, Koftis TV, Converso A, Loizidou E, Kaiser F, Roecker AJ, Dellios CC, Sun XW, Petrovic G. Studies toward the synthesis of azadirachtin, part 2: construction of fully functionalized ABCD ring frameworks and unusual intramolecular reactions induced by close-proximity effects. Angewandte Chemie (International Ed. in English). 44: 3447-52. PMID 15849805 DOI: 10.1002/Anie.200500217  0.96
2005 Nicolaou KC, Sasmal PK, Roecker AJ, Sun XW, Mandal S, Converso A. Studies toward the synthesis of azadirachtin, part 1: total synthesis of a fully functionalized ABC ring framework and coupling with a norbornene domain. Angewandte Chemie (International Ed. in English). 44: 3443-7. PMID 15846829 DOI: 10.1002/Anie.200500216  0.96
2004 Converso A, Saaidi PL, Sharpless KB, Finn MG. Nucleophilic substitution by grignard reagents on sulfur mustards. The Journal of Organic Chemistry. 69: 7336-9. PMID 15471488 DOI: 10.1021/Jo0489869  0.76
2001 Converso A, Burow K, Marzinzik A, Sharpless KB, Finn MG. 2,6-Dichloro-9-thiabicyclo[3.3.1]nonane: a privileged, bivalent scaffold for the display of nucleophilic components. The Journal of Organic Chemistry. 66: 4386-92. PMID 11397181 DOI: 10.1021/Jo015632Y  0.96
1999 Adolfsson H, Converso A, Sharpless KB. Comparison of amine additives most effective in the new methyltrioxorhenium-catalyzed epoxidation process Tetrahedron Letters. 40: 3991-3994. DOI: 10.1016/S0040-4039(99)00661-9  0.96
Show low-probability matches.